Cancer Analysis Firm PGDx Licenses Genome Mapping Technology from Johns Hopkins | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer genetic analysis firm Personal Genome Diagnostics today announced it has licensed the exclusive rights to the Digital Karyotyping genome mapping technology from Johns Hopkins University.

The technology was developed by the company's founders, who also hold positions at the university. Under the terms of the deal, PGDx can sublicense the DK technology to third parties. Further details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.